ࡱ> FE  T\pVelisage-10 B=K_8X@"1 Aptos Narrow1 Aptos Narrow1 Aptos Narrow1 Aptos Narrow1 Aptos Narrow1h6 Aptos Narrow1,6 Aptos Narrow16 Aptos Narrow16 Aptos Narrow1 Aptos Narrow14 Aptos Narrow14 Aptos Narrow1  Aptos Narrow1  Aptos Narrow1 Aptos Narrow1 Aptos Narrow1  Aptos Narrow1 Aptos Narrow1 Aptos Narrow1 Aptos Narrow1 Aptos Narrow1< Aptos Narrow1? Aptos Narrow1> Aptos Narrow1  Aptos Narrow18 Aptos Narrow18 Aptos Narrow1 Aptos Narrow14 Aptos Narrow1  Aptos Narrow1  Aptos Narrow1 Aptos Narrow"?"\ #,##0;"?"\ \-#,##0"?"\ #,##0;[Red]"?"\ \-#,##0 "?"\ #,##0.00;"?"\ \-#,##0.00%""?"\ #,##0.00;[Red]"?"\ \-#,##0.00;*8_ "?"\ * #,##0_ ;_ "?"\ * \-#,##0_ ;_ "?"\ * "-"_ ;_ @_ ,))_ * #,##0_ ;_ * \-#,##0_ ;_ * "-"_ ;_ @_ C,@_ "?"\ * #,##0.00_ ;_ "?"\ * \-#,##0.00_ ;_ "?"\ * "-"??_ ;_ @_ 4+1_ * #,##0.00_ ;_ * \-#,##0.00_ ;_ * "-"??_ ;_ @_ "?"#,##0;"?"\-#,##0"?"#,##0;[Red]"?"\-#,##0"?"#,##0.00;"?"\-#,##0.00!"?"#,##0.00;[Red]"?"\-#,##0.0052_ "?"* #,##0_ ;_ "?"* \-#,##0_ ;_ "?"* "-"_ ;_ @_ =:_ "?"* #,##0.00_ ;_ "?"* \-#,##0.00_ ;_ "?"* "-"??_ ;_ @_ \$#,##0_);\(\$#,##0\)\$#,##0_);[Red]\(\$#,##0\)\$#,##0.00_);\(\$#,##0.00\)# \$#,##0.00_);[Red]\(\$#,##0.00\)                                       A.I. + )    @}  b A.I.   A~I~    }|   @Y     A,I,         i     20% - Accent1A 20% - Accent1 % 20% - Accent4M* 20% - Accent4 ef % 20% - ?? 2w 20% - ?? 3w 20% - ?? 5%  20% - ?? 6%  40% - Accent1M 40% - Accent1 L % 40% - Accent4M+ 40% - Accent4 L % 40% - ?? 2%  40% - ?? 3%  40% - ?? 5%  40% - ?? 6%  60% - Accent4M, 60% - Accent4 23a % 60% - Accent5M0 60% - Accent5 23m % 60% - ?? 1%  60% - ?? 2%  60% - ?? 3% ! 60% - ?? 6%  "Accent25!Accent2 % #Accent45)Accent4 %$Bad-Bad %% Calculationi Calculation% & Comma'( Comma [0](&Currency). Currency [0] * Heading 1( Heading 1 + Heading 3( Heading 3,InputiInput ??v%  -NeutralANeutral  W%3Normal % .OutputkOutput ???%????????? ???/$Percent0Title Title1Total1Total %2?? 3?? 2?? 4?? 4?? 5??????6?? 5 7?? 1?? 8?? 3?? 9?? 5?? :?? 6?? ;?????? <?????? =??????83ffff̙3f3fff3f3f33333f33333WTable S6  T fKY2Kdi  dMbP?_*+%,[&ffffff?'ffffff?(?)?"[D S6333333?333333?U f  ,? ,? , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,d@\Supplementary Table 6. The results of GO analysis (Molecular Function) in GSE33382 data set.?geneSet? description ?size?overlap?expect?enrichmentRatio?pValue ?FDR?userId GO:0097109)!neuroligin family protein binding@@2ʯL?im!yK@>LnA?N/(? NRXN2;DLG4 GO:0008270zinc ion binding@.@`<@X5G@>!'*K?N/(?ZRMT1F;MT1X;MT1A;MT1M;MT2A;ZCCHC9;MT1E;MTR;ZZZ3;PHC1;GTF2B;ADAMTS9;MORC1;RCHY1;TRAF5 GO:0008172$S-methyltransferase activity@@packq?_<\C@5"R?N/(?MTR;INMT GO:0017154$semaphorin receptor activity&@@|`ƴ?n8E8@|Jg?~ ? PLXNA2;PLXND1 GO:0004861KCcyclin-dependent protein serine/threonine kinase inhibitor activity(@@+ \?[[6@MVk?~ ? CDKN2A;HEXIM2 GO:0019207!kinase regulator activityi@@ۗ? @!Wӽp?~ ?.&MAP2K1;TRIB2;CDKN2A;HEXIM2;CCND1;BCL10 GO:0016538KCcyclin-dependent protein serine/threonine kinase regulator activityF@@ҩJ??k'P"@ Z6,r?~ ?CDKN2A;HEXIM2;CCND1  GO:0046914$ transition metal ion binding @0@ CZ9@ >{e@ 7l1s?~ ?a YMT1F;MT1X;MT1A;MT1M;MT2A;ZCCHC9;MT1E;MTR;ZZZ3;PHC1;GTF2B;ADAMTS9;CYP4F2;MORC1;RCHY1;TRAF5  GO:0050700 CARD domain binding .@@ Ŷ T? 8P2@ :u?~ ?  BCL10;CARD9  GO:0050780! dopamine receptor binding 1@@ 2?  /@ Dn{?~ ?  PALM;DLG4  GO:0005005. &transmembrane-ephrin receptor activity 1@@ 2?  /@ Dn{?~ ?  EPHB4;EPHA4  GO:0008134$ transcription factor binding @&@ "v0@ ױ@ ٳ%?~ ?E =RCOR3;TRIB2;YY2;TLE6;MEF2D;GTF2B;CDKN2A;CCND1;HDGF;BCL10;HES1 GO:00083202*protein transmembrane transporter activity3@@x݈?tf,@xGrk?~ ? MCL1;SEC61G GO:0005003 ephrin receptor activity3@@x݈?tf,@xGrk?~ ? EPHB4;EPHA4 GO:0019887)!protein kinase regulator activitye@@ 䛨?eM@~?~ ?( MAP2K1;TRIB2;CDKN2A;HEXIM2;CCND1 GO:0004860)!protein kinase inhibitor activityO@@+oF?;@~?~ ?TRIB2;CDKN2A;HEXIM2 GO:002288480macromolecule transmembrane transporter activity6@@=^?n8E(@2?~ ? MCL1;SEC61G GO:0001965'G-protein alpha-subunit binding6@@=^?n8E(@2?~ ? GPSM2;HTR2A GO:0019904'protein domain specific binding`@&@ /@#o@9Xo*?n8E@g95?~ ?TRIB2;CDKN2A;HEXIM2 GO:0002020protease binding_@@ F?aW}@>Q~?~ ? MAGEA3;DERL1;BCL10;CFLAR GO:0051059NF-kappaB binding<@@packq?~ȧ<\#@A̤p?~ ? CDKN2A;BCL10 GO:19046802*peptide transmembrane transporter activity?@@OF?aW}!@)Я\?~ ? MCL1;SEC61G GO:0030291:2protein serine/threonine kinase inhibitor activity@@@=T>*?Lƽm @-A&?~ ? CDKN2A;HEXIM2 GO:0008565$protein transporter activity@V@@HdTE?8KF@/9̜?~ ?COG2;MCL1;SEC61G GO:0098772$molecular function regulatorМ@5@5+@͑K?uB;=?~ ?MAP2K1;COPA;GPSM2;TRIB2;SLN;RAB3GAP2;NRXN2;SPTBN4;RGS5;CDKN2A;HEXIM2;CCND1;SPATA13;CCL28;HDGF;BCL10;CNIH3;CFLAR;DLG4;PYGO2;IFNA17 GO:0003714*"transcription corepressor activity`m@@i^ؽ? tB@uaa?~ ?"RCOR3;TLE6;CCND1;HDGF;HES1 GO:0016709oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenC@@CYވ?\7f@)ȁY?~ ? CYP4F2;SQLE GO:0051434BH3 domain binding@?2ʯL?!y;@CbFn ?~ ? MCL1 GO:0099181,$structural constituent of presynapse@?2ʯL?!y;@CbFn ?~ ?PPFIA2Dlh%7 ,! ," ,# ,$ ,% ,& ,' ,( ,) ,* ,+ ,, ,- ,. ,/ ,0 ,1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,: ,; ,< ,= ,> ,? ,  GO:1902387$ ceramide 1-phosphate binding @? 2ʯL? !y;@ CbFn ?~ ? PLEKHA8! GO:19023881!)ceramide 1-phosphate transporter activity!@?!2ʯL?!!y;@!CbFn ?~ !?!PLEKHA8" GO:00428870"(amide transmembrane transporter activity"F@@"_?"n8E@"!>b?~ "?" MCL1;SEC61G# GO:0017176E#=phosphatidylinositol N-acetylglucosaminyltransferase activity#@?#+ \?#[[6@#178A?~ #? #PIGY$ GO:0031849"$olfactory receptor binding$@?$+ \?$[[6@$178A?~ $? $REEP1% GO:0032813:%2tumor necrosis factor receptor superfamily binding%G@@%I5?%1S@%1N,?~ %?% TRAF5;CFLAR& GO:0042826#&histone deacetylase binding&[@@&=w?&QU @&SEG+$?~ &?&MEF2D;CCND1;HES1' GO:0008022"'protein C-terminus binding'`g@@'&A?'d1@'<~?~ '?'MAP2K1;GPSM2;BCL10;DLG4( GO:0102991(( myristoyl-CoA hydrolase activity(@?(packq?(_<\3@(ީ?~ (? (THEM4) GO:0097322)7SK snRNA binding)@?)packq?)_<\3@)ީ?~ )?)HEXIM2* GO:0005004+*#GPI-linked ephrin receptor activity*@?*packq?*_<\3@*ީ?~ *? *EPHA4+ GO:0015450M+EP-P-bond-hydrolysis-driven protein transmembrane transporter activity+@?+packq?+_<\3@+ީ?~ +?+SEC61G, GO:0016713,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen, @?,,z8?,̖+0@,f)u?~ ,?,CYP4F2- GO:0035620%-ceramide transporter activity- @?-,z8?-̖+0@-f)u?~ -?-PLEKHA8. GO:0008568,.$microtubule-severing ATPase activity. @?.,z8?.̖+0@.f)u?~ .?.FIGNL1/ GO:0120013-/%intermembrane lipid transfer activity/ @?/,z8?/̖+0@/f)u?~ /?/PLEKHA80 GO:0043621 0protein self-association0K@@0=w?0j@06ޯ?~ 0?0 GPSM2;BCL101 GO:0031748$1D1 dopamine receptor binding1"@?1ݠ0?1U^.@1 󌂂?~ 1? 1DLG42 GO:0097110 2scaffold protein binding2M@@2Y8/c?2ױ@2NA}?~ 2?2 MAP2K1;DLG43 GO:0005347.3&ATP transmembrane transporter activity3$@?3,PL?3!y+@3"CG?~ 3?3SLC25A234 GO:00514004BH domain binding4$@?4,PL?4!y+@4"CG?~ 4? 4MCL15 GO:00705135death domain binding5$@?5,PL?5!y+@5"CG?~ 5? 5MCL16 GO:00314196cobalamin binding6$@?6,PL?6!y+@6"CG?~ 6? 6MTR7 GO:00431767 amine binding7$@?7,PL?7!y+@7"CG?~ 7? 7HTR2A8 GO:00513788serotonin binding8$@?8,PL?8!y+@8"CG?~ 8? 8HTR2A9 GO:0030234!9enzyme regulator activity9Џ@(@9@4& @9IN?9:'{?~ 9?R9JMAP2K1;GPSM2;TRIB2;SLN;RAB3GAP2;RGS5;CDKN2A;HEXIM2;CCND1;BCL10;CFLAR;PYGO2: GO:00085250:(phosphatidylcholine transporter activity:&@?:|`ƴ?:n8E(@:_`?~ :? :ABCA7; GO:0031996;thioesterase binding;&@?;|`ƴ?;n8E(@;_`?~ ;? ;TRAF5< GO:0070181,<$small ribosomal subunit rRNA binding<&@?<|`ƴ?<n8E(@<_`?~ <?<MRPS18C= GO:0005542=folic acid binding=&@?=|`ƴ?=n8E(@=_`?~ =? =MTHFS> GO:0033130&>acetylcholine receptor binding>&@?>|`ƴ?>n8E(@>_`?~ >? >DLG4? GO:0089720?caspase binding?&@??|`ƴ??n8E(@?_`?~ ???MAGEA3DlF@ ,A ,B ,C ,D ,E ,F ,G ,H ,I ,J ,K ,L ,M ,N ,O ,P ,Q ,R ,S ,T ,U ,V ,W ,X ,Y ,Z ,[ ,\ ,] ,^ ,_ ,@ GO:0046624)@!sphingolipid transporter activity@&@?@|`ƴ?@n8E(@@_`?~ @?@PLEKHA8A GO:0005548)A!phospholipid transporter activityAO@@AںΘ?A:.'6@A=/N/?~ A?A ABCA7;PLEKHA8B GO:0004714?B7transmembrane receptor protein tyrosine kinase activityBP@@BFz8?B-+@Bj ?~ B?B EPHB4;EPHA4C GO:0046906Ctetrapyrrole bindingC@a@@C='rJ?C1S@Cb ?~ C?CMTR;TPO;CYP4F2D GO:0003995'Dacyl-CoA dehydrogenase activityD(@?D+ \?Dy&@Dd1]Ƶ?~ D? DACADME GO:0043422 Eprotein kinase B bindingE(@?E+ \?Ey&@Ed1]Ƶ?~ E? EBCL10F GO:0016290(F palmitoyl-CoA hydrolase activityF(@?F+ \?Fy&@Fd1]Ƶ?~ F? FTHEM4G GO:0097001Gceramide bindingG(@?G+ \?Gy&@Gd1]Ƶ?~ G?GPLEKHA8H GO:0031005Hfilamin bindingH*@?H {㍸?H|h$@Hi?~ H?HTMEM67I GO:0015373'Ianion:sodium symporter activityI*@?I {㍸?I|h$@Ii?~ I?ISLC5A5J GO:0005319"Jlipid transporter activityJ b@@J?J8$o@J Ǔ?~ J?JABCA7;OSBPL9;PLEKHA8K GO:0015370(K solute:sodium symporter activityKQ@@K<0T?KVH@K罸?~ K?K SLC5A5;SLC5A9L GO:0005092+L#GDP-dissociation inhibitor activityL,@?Lpackq?L~ȧ<\#@L{ 8?~ L? LGPSM2M GO:00314347M/mitogen-activated protein kinase kinase bindingM,@?Mpackq?M~ȧ<\#@M{ 8?~ M? MTRIB2N GO:0070491/N'repressing transcription factor bindingN@R@@N75  Oh+'0x8@L X dp???QC@D@3L ՜.+,00 8@ H ]  Table S6  Worksheets  !"#$%&'()*+,-./012346789:;<>?@ABCDRoot EntryF;]Book iSummaryInformation(5DocumentSummaryInformation8=